Before Aurobindo can complete its acquisition of Pennsylvania generics specialist Lannet, it will have to divest four drugs from the proposed $250 million buyout to resolve anticompetitive concerns, the Federal Trade Commission said. More: FTC orders Aurobindo to divest 4
read morePfizer’s CFO Dave Denton will officially depart in August, leaving SVP of finance Cecile Guegan to take up his post in the interim. More: Pfizer hunts for new CFO as Denton prepares to hang up gloves, wave goodbye to pharma
read moreWith interest in automated cell therapy production beginning to build from about 2016 onward, some 23 companies working in the field have now raised a collective $1.1 billion across 34 rounds through April 24, data intelligence platform Tracxn said in
read moreName recognition and “familiarity” with Novo Nordisk’s oral Wegovy has contributed to its rapid uptake in its battle with Lilly’s oral GLP-1 Foundayo, according to Spherix analyst Jim Hickey, who conducts monthly surveys with doctors who prescribe the treatments. More:
read more© 1994 - 2026 B.M. Pharmaceuticals